Palvella Therapeutics, Inc. — Form D/A

Palvella Therapeutics, Inc. of WAYNE, PA, a company, filed a Form D amendment with the SEC on 2019-08-12. The offering totals $5.0M, of which $4.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Michael H ChristopherDirectorWayne, PA
Timothy H HenkelDirectorWayne, PA
Todd DavisRelated PersonWayne, PA
Elaine HeronRelated PersonAnn Arbor, MI
Michael ChristopherRelated PersonWayne, PA
Aditya H AsokanDirectorWayne, PA
Wesley H KaupinenDirectorWayne, PA
Wesley H KaupinenExecutive OfficerWayne, PA
Jeffrey S MartiniExecutive OfficerWayne, PA
Tadd S WesselDirectorWayne, PA
Kathleen S McGowanExecutive OfficerWayne, PA
George H JenkinsDirectorWayne, PA
Todd H DavisDirectorWayne, PA
Scott H MorensteinDirectorWayne, PA
Kathleen S GoinExecutive OfficerWayne, PA
Kathleen A McGowanExecutive OfficerWayne, PA
Kathleen A GoinExecutive OfficerWayne, PA
John H DouxDirectorWayne, PA
Cory H FreedlandDirectorWayne, PA
Braham A Shroot, Ph.D.Executive OfficerWayne, PA
Elaine H HeronDirectorWayne, PA
George JenkinsRelated PersonWayne, PA
David H TierneyDirectorWayne, PA
Timothy HenkelRelated PersonWayne, PA
Wesley H. KaupinenRelated PersonWayne, PA

Other filings by this issuer (4)

FiledFormOfferingSold
2022-12-30D$37.7M$9.7M
2020-06-03D$45.0M$45.0M
2019-04-12D$4.0M$3.4M
2018-06-14D$5.0M$4.4M

More